info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Hypothyreosis and Thyroxine purchase for inclusion criteria

HYPOT_THYRO_INCL

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E03
Cause of death: ICD-10 E03
Medicine purchases: ATC H03AA01

3 out of 7 registries used, show all original rules.

54714

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

54714

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

54821

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

52943

diagram downward connector
HYPOT_THYRO_INCL

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF8

Similar endpoints

List of similar endpoints to Hypothyreosis and Thyroxine purchase for inclusion criteria based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 52943 42200 10743
Unadjusted prevalence (%) 12.85 18.33 5.91
Mean age at first event (years) 51.49 49.75 58.29

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: HYPOT_THYRO_INCL – Hypothyreosis and Thyroxine purchase for inclusion criteria
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Hypothyreosis and Thyroxine purchase for inclusion criteria

Endpoint not on priority list, no data to show.